CXCL8 and depressive symptom measurement: Here we report that an increase in IL-8 from baseline to post-treatment (24 h following ketamine infusion) was associated with a favorable depression treatment response to ketamine infusion in females, whereas increase in IL-8 was associated with an unfavorable treatment response in males.